Generics News
-
Juno Therapeutics signs three license agreements
Generics | News | 0 Comment | 11 Dec, 2017
US based biopharma company Juno Therapeutics has announced three license agreements to advance its program in multiple myeloma using gamma secretase inhibitors (GSIs) in combination with BC...Read more
-
FDA approves Amgen's Repatha (evolocumab)
Generics | News | 0 Comment | 07 Dec, 2017
Amgen has announced that following priority review of its supplemental Biologics License Application, the U.S. Food and Drug Administration (FDA) approved Repatha (evolocumab) as ...Read more
-
Generics | News | 0 Comment | 01 Dec, 2017
Jeong Woo Cho, Ph.D., has been appointed president and CEO of SK biopharmaceuticals and SK life science to lead the company through the next phase of its evolution. Dr. Cho began hi...Read more
-
Generics | News | 0 Comment | 30 Nov, 2017
Singapore – Janssen Asia Pacific announced it has supported the establishment of the first-of-its-kind Asia Pacific Prostate Cancer Patient Coalition with the goal to address the chal...Read more
-
Biohaven receives agreement from FDA on initial pediatric study plan
Generics | News | 0 Comment | 28 Nov, 2017
Biohaven Pharmaceutical Holding Company Ltd. has announced that the Company has received agreement from the U.S. Food and Drug Administration (FDA) on the initial pediatric study plan (iPSP...Read more
-
Biogen and Alkermes announce license and collaboration agreement
Generics | News | 0 Comment | 28 Nov, 2017
US based biotech company Biogen and pharma company Alkermes has announced that they have entered into a global license and collaboration agreement to develop and commercialize ALKS 87...Read more
-
GSK submits landmark IMPACT data to USFDA for the use of Trelegy Ellipta
Generics | News | 0 Comment | 27 Nov, 2017
Pharma company, GlaxoSmithKline and Innoviva has announced the filing of a supplemental New Drug Application (sNDA) with the US Food and Drug Administration (FDA) for the use of Trelegy Ell...Read more
-
Puma biotech and Specialised Therapeutics signs agreement to commercialize NERLYNX®
Generics | News | 0 Comment | 24 Nov, 2017
Puma Biotechnology and Specialised Therapeutics Asia Enter into Exclusive Licensing Agreement to Commercialize NERLYNX® (neratinib) in Australia, New Zealand and South East Asia Biopha...Read more
-
Step Pharma completes €14.5 million Series A financing
Generics | News | 0 Comment | 23 Nov, 2017
France based Step Pharma has announced the closing of a Series A financing totalling €14.5 million. Pontifax will join existing investors led by Kurma Partners, and including Bpifranc...Read more
-
FDA approves RxSight's light adjustable lens
Generics | News | 0 Comment | 23 Nov, 2017
Singapore – RxSight (a US based medical devices company) announced that the U.S. Food and Drug Administration (FDA) has approved the RxSight Light Adjustable Lens and the Light Delive...Read more
-
PeptiDream announces collaboration with Bayer
Generics | News | 0 Comment | 21 Nov, 2017
Japan based biopharma company PeptiDream Inc. has announced that it has entered into a multi-target discovery collaboration with Germany-based Bayer AG. Under the agreement, PeptiDream wil...Read more
-
Ionis Pharmaceuticals licenses second antisense GI Drug to Janssen
Generics | News | 0 Comment | 17 Nov, 2017
U.S. based Pharma Company Ionis Pharmaceuticals, Inc. has announced that it has licensed a second orally delivered Generation 2.5 antisense drug to Janssen Biotech, Inc. (Janssen)...Read more
-
Cue Biopharma announces research collaboration with Merck
Generics | News | 0 Comment | 17 Nov, 2017
US based pharma company Cue Biopharma™, Inc. has announced a strategic strategic research collaboration and license agreement with Merck. Under the terms of the deal, the CUE Biologi...Read more
-
Generic Acticlate tablets launched by Lupin in USA
Generics | News | 0 Comment | 06 Nov, 2017
Pharma Major Lupin announced the launch of its Doxycycline Hyclate Tablets USP, 75 mg and 150 mg after an approval from the United States Food and Drug Administration (FDA). Lupin’s ...Read more
-
Lupin net profit falls 31% in Q2 to Rs 455
Generics | News | 0 Comment | 31 Oct, 2017
Pharma company Lupin reported its financial performance for the second quarter ending September 30th, 2017. The company reported net profit of Rs 662.9 in the same period of previous year....Read more
-
Lupin receives FDA approval for generic Axiron topical solution
Generics | News | 0 Comment | 27 Oct, 2017
Pharma Major Lupin has received final approval for its Testosterone Topical Solution, 30 mg per actuation from the United States Food and Drug Administration (FDA) to market a generic versi...Read more
-
Lupin receives FDA approval for generic Lodosyn tablets and Kapvay Extended-Release tablets
Generics | News | 0 Comment | 27 Oct, 2017
Pharma Major Lupin has announced that it has received final approval for its Carbidopa Tablets, 25 mg and Clonidine Hydrochloride Extended-Release Tablets, 0.1 mg from the United States Foo...Read more
-
US FDA approves Bydureon BCise by AstraZeneca for type-2 diabetes
Generics | News | 0 Comment | 23 Oct, 2017
Biopharma company AstraZeneca has announced its US Food and Drug Administration (FDA) approved Bydureon BCise (exenatide extended-release) injectable suspension. The new for...Read more
